Analyze Diet
Veterinary sciences2023; 10(2); 78; doi: 10.3390/vetsci10020078

Voluntary Biosurveillance of Streptococcus equi Subsp. equi in Nasal Secretions of 9409 Equids with Upper Airway Infection in the USA.

Abstract: This study aimed to describe selected epidemiological aspects of horses with acute onset of fever and respiratory signs testing qPCR-positive for and to determine the effect of vaccination against on qPCR status. Horses with acute onset of fever and respiratory signs from all regions of the United States were included in a voluntary biosurveillance program from 2008 to 2020 and nasal secretions were tested via qPCR for and common respiratory viruses. A total of 715/9409 equids (7.6%) tested qPCR-positive for , with 226 horses showing coinfections with EIV, EHV-1, EHV-4, and ERBV. The median age for the qPCR-positive horses was 8 ± 4 years and there was significant difference when compared to the median age of the qPCR-negative horses (6 ± 2 years; = 0.004). Quarter Horse, Warmblood, and Thoroughbred were the more frequent breed in this horse population, and these breeds were more likely to test qPCR-positive for compared to other breeds. There was not statistical difference for sex between qPCR-positive and qPCR-negative horses. Horses used for competition and ranch/farm use were more likely to test qPCR-positive for ( = 0.006). Horses that tested qPCR-positive were more likely to display nasal discharge, fever, lethargy, anorexia, and ocular discharge compared to horses that tested qPCR-negative ( = 0.001). Vaccination against was associated with a lower frequency of qPCR-positive status.
Publication Date: 2023-01-20 PubMed ID: 36851382PubMed Central: PMC9962190DOI: 10.3390/vetsci10020078Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses a study conducted on horses in the United States from 2008 to 2020, monitoring for the presence of Streptococcus equi bacteria in the nasal secretions of equids showing symptoms of upper respiratory infections. Despite vaccination efforts, 7.6% of the horses tested were found to be positive for the bacteria strain.

Objective of the Research

  • The primary goal of this study was to observe and gather data on horses displaying symptoms of fever and respiratory signs that tested positive via qPCR for Streptococcus equi, a bacteria typically associated with upper respiratory infections in horses.
  • Alongside this, the study sought to assess the effectiveness of vaccinations against Streptococcus equi, by comparing the qPCR status of vaccinated horses with those that were unvaccinated.

Methodology

  • The study took place over a twelve-year period, from 2008 to 2020, and included horses from all regions of the United States.
  • Nasal secretions were collected from a total of 9409 horses which were experiencing symptoms of acute fever and respiratory issues. These samples were then tested using qPCR for the presence of Streptococcus equi and also for common respiratory viruses.

Findings

  • The qPCR test returned positive results for Streptococcus equi in 715 equids (or 7.6% of the study population). Of these, 226 horses were found to have co-infections with equine influenza virus (EIV), equine herpesvirus-1 (EHV-1), equine herpesvirus-4 (EHV-4), and equine rhinitis B virus (ERBV).
  • The median age of the horses testing positive for Streptococcus equi was 8 years, while the median age of horses testing negative was 6 years. This age difference was found to be statistically significant.
  • The most commonly affected breeds included Quarter Horses, Warmbloods, and Thoroughbreds. These breeds were also more likely to test positive for Streptococcus equi when compared to other horse breeds.
  • The study found no significant difference in the likelihood to test positive for the bacteria between different genders of horse.
  • Horses used for competition or on a ranch/farm were more likely to test positive for Streptococcus equi.
  • Horses that tested positive for the bacteria were more likely to show symptoms such as nasal discharge, fever, lethargy, anorexia, and ocular discharge when compared to those testing negative.
  • Vaccination against Streptococcus equi was generally associated with a lower likelihood of testing positive for the bacteria. This suggests that the vaccine was at least partially effective as a preventative measure against the nasal bacteria.

Cite This Article

APA
Jaramillo-Morales C, James K, Barnum S, Vaala W, Chappell DE, Schneider C, Craig B, Bain F, Barnett DC, Gaughan E, Pusterla N. (2023). Voluntary Biosurveillance of Streptococcus equi Subsp. equi in Nasal Secretions of 9409 Equids with Upper Airway Infection in the USA. Vet Sci, 10(2), 78. https://doi.org/10.3390/vetsci10020078

Publication

ISSN: 2306-7381
NlmUniqueID: 101680127
Country: Switzerland
Language: English
Volume: 10
Issue: 2
PII: 78

Researcher Affiliations

Jaramillo-Morales, Camilo
  • William R. Pritchard Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
James, Kaitlyn
  • Department of Obstetrics, Gynecology and Reproduction Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
Barnum, Samantha
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Vaala, Wendy
  • Merck Animal Health, Madison, NJ 07940, USA.
Chappell, Duane E
  • Merck Animal Health, Madison, NJ 07940, USA.
Schneider, Chrissie
  • Merck Animal Health, Madison, NJ 07940, USA.
Craig, Bryant
  • Merck Animal Health, Madison, NJ 07940, USA.
Bain, Fairfield
  • Merck Animal Health, Madison, NJ 07940, USA.
Barnett, D Craig
  • Merck Animal Health, Madison, NJ 07940, USA.
Gaughan, Earl
  • Merck Animal Health, Madison, NJ 07940, USA.
Pusterla, Nicola
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.

Grant Funding

  • 1 / Merck Animal Health

Conflict of Interest Statement

C.J.-M., K.J., S.B. and N.P. declare no conflict of interest. W.V., D.E.C., C.S., B.C., F.B., D.C.B. and E.G. work for Merck Animal Health.

References

This article includes 25 references
  1. Paillot R, Lopez-Alvarez MR, Newton JR, Waller AS. Strangles: A modern clinical view from the 17th century.. Equine Vet J 2017 Mar;49(2):141-145.
    doi: 10.1111/evj.12659pubmed: 28177153google scholar: lookup
  2. Waller AS. Strangles: a pathogenic legacy of the war horse.. Vet Rec 2016 Jan 23;178(4):91-2.
    doi: 10.1136/vr.i123pubmed: 26795860google scholar: lookup
  3. Pusterla N, Kass PH, Mapes S, Johnson C, Barnett DC, Vaala W, Gutierrez C, McDaniel R, Whitehead B, Manning J. Surveillance programme for important equine infectious respiratory pathogens in the USA.. Vet Rec 2011 Jul 2;169(1):12.
    doi: 10.1136/vr.d2157pubmed: 21676986google scholar: lookup
  4. Sweeney CR, Timoney JF, Newton JR, Hines MT. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles.. J Vet Intern Med 2005 Jan-Feb;19(1):123-34.
  5. Boyle AG, Timoney JF, Newton JR, Hines MT, Waller AS, Buchanan BR. Streptococcus equi Infections in Horses: Guidelines for Treatment, Control, and Prevention of Strangles-Revised Consensus Statement.. J Vet Intern Med 2018 Mar;32(2):633-647.
    doi: 10.1111/jvim.15043pmc: PMC5867011pubmed: 29424487google scholar: lookup
  6. Morris ERA, Hillhouse AE, Konganti K, Wu J, Lawhon SD, Bordin AI, Cohen ND. Comparison of whole genome sequences of Streptococcus equi subsp. equi from an outbreak in Texas with isolates from within the region, Kentucky, USA, and other countries.. Vet Microbiol 2020 Apr;243:108638.
    pubmed: 32273017doi: 10.1016/j.vetmic.2020.108638google scholar: lookup
  7. Kemp-Symonds J, Kemble T, Waller A. Modified live Streptococcus equi ('strangles') vaccination followed by clinically adverse reactions associated with bacterial replication.. Equine Vet J 2007 May;39(3):284-6.
    doi: 10.2746/042516407X195961pubmed: 17520983google scholar: lookup
  8. McGlennon A, Waller A, Verheyen K, Slater J, Grewar J, Aanensen D, Newton R. Surveillance of strangles in UK horses between 2015 and 2019 based on laboratory detection of Streptococcus equi.. Vet Rec 2021 Dec;189(12):e948.
    doi: 10.1002/vetr.948pubmed: 34570896google scholar: lookup
  9. Libardoni F, Machado G, Gressler LT, Kowalski AP, Diehl GN, dos Santos LC, Corbellini LG, de Vargas AC. Prevalence of Streptococcus equi subsp. equi in horses and associated risk factors in the State of Rio Grande do Sul, Brazil.. Res Vet Sci 2016 Feb;104:53-7.
    pubmed: 26850537doi: 10.1016/j.rvsc.2015.11.009google scholar: lookup
  10. Jaramillo-Morales C, Gomez DE, Renaud D, Arroyo LG. Streptococcus equi culture prevalence, associated risk factors and antimicrobial susceptibility in a horse population from Colombia.. J Equine Vet Sci 2022 Apr;111:103890.
    doi: 10.1016/j.jevs.2022.103890pubmed: 35124153google scholar: lookup
  11. Clark C, Greenwood S, Boison JO, Chirino-Trejo M, Dowling PM. Bacterial isolates from equine infections in western Canada (1998-2003).. Can Vet J 2008 Feb;49(2):153-60.
    pmc: PMC2216435pubmed: 18309745
  12. Ling AS, Upjohn MM, Webb K, Waller AS, Verheyen KL. Seroprevalence of Streptococcus equi in working horses in Lesotho.. Vet Rec 2011 Jul 16;169(3):72.
    doi: 10.1136/vr.d1725pubmed: 21709046google scholar: lookup
  13. Tirosh-Levy S, Blum SE, Steward KF, Waller AS, Steinman A. Streptococcus equi subspecies equi in horses in Israel: seroprevalence and strain types.. Vet Rec Open 2016;3(1):e000187.
    doi: 10.1136/vetreco-2016-000187pmc: PMC5013422pubmed: 27651915google scholar: lookup
  14. Laing G, Christley R, Stringer A, Aklilu N, Ashine T, Newton R, Radford A, Pinchbeck G. Respiratory disease and sero-epidemiology of respiratory pathogens in the working horses of Ethiopia.. Equine Vet J 2018 Nov;50(6):793-799.
    doi: 10.1111/evj.12834pmc: PMC6175379pubmed: 29574904google scholar: lookup
  15. Pringle J, Venner M, Tscheschlok L, Waller AS, Riihimäki M. Markers of long term silent carriers of Streptococcus equi ssp. equi in horses.. J Vet Intern Med 2020 Nov;34(6):2751-2757.
    doi: 10.1111/jvim.15939pmc: PMC7694814pubmed: 33074578google scholar: lookup
  16. Ferraro S, Fecteau G, Dubuc J, Francoz D, Rousseau M, Roy JP, Buczinski S. Scoping review on clinical definition of bovine respiratory disease complex and related clinical signs in dairy cows.. J Dairy Sci 2021 Jun;104(6):7095-7108.
    doi: 10.3168/jds.2020-19471pubmed: 33741167google scholar: lookup
  17. D○ LR, Stefanovski D, Boston RC, Boyle AG. Predictor variables for and complications associated with Streptococcus equi subsp equi infection in horses.. J Am Vet Med Assoc 2015 Nov 15;247(10):1161-8.
    doi: 10.2460/javma.247.10.1161pubmed: 26517620google scholar: lookup
  18. Waller AS. New perspectives for the diagnosis, control, treatment, and prevention of strangles in horses.. Vet Clin North Am Equine Pract 2014 Dec;30(3):591-607.
    doi: 10.1016/j.cveq.2014.08.007pubmed: 25300634google scholar: lookup
  19. Tscheschlok L, Venner M, Steward K, Böse R, Riihimäki M, Pringle J. Decreased Clinical Severity of Strangles in Weanlings Associated with Restricted Seroconversion to Optimized Streptococcus equi ssp equi Assays.. J Vet Intern Med 2018 Jan;32(1):459-464.
    doi: 10.1111/jvim.15037pmc: PMC5787152pubmed: 29377359google scholar: lookup
  20. Hoffman AM, Staempfli HR, Prescott JF, Viel L. Field evaluation of a commercial M-protein vaccine against Streptococcus equi infection in foals.. Am J Vet Res 1991 Apr;52(4):589-92.
    pubmed: 2053730
  21. Robinson C, Waller AS, Frykberg L, Flock M, Zachrisson O, Guss B, Flock JI. Intramuscular vaccination with Strangvac is safe and induces protection against equine strangles caused by Streptococcus equi.. Vaccine 2020 Jun 26;38(31):4861-4868.
    doi: 10.1016/j.vaccine.2020.05.046pubmed: 32507408google scholar: lookup
  22. Jacobs AA, Goovaerts D, Nuijten PJ, Theelen RP, Hartford OM, Foster TJ. Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi.. Vet Rec 2000 Nov 11;147(20):563-7.
    doi: 10.1136/vr.147.20.563pubmed: 11104039google scholar: lookup
  23. Robinson C, Heather Z, Slater J, Potts N, Steward KF, Maskell DJ, Fontaine MC, Lee JJ, Smith K, Waller AS. Vaccination with a live multi-gene deletion strain protects horses against virulent challenge with Streptococcus equi.. Vaccine 2015 Feb 25;33(9):1160-7.
    doi: 10.1016/j.vaccine.2015.01.019pubmed: 25597942google scholar: lookup
  24. Boyle AG, Mitchell C, Stefanovski D, Waller AS. Horses vaccinated with live attenuated intranasal strangles vaccine seroconvert to SEQ2190 and SeM.. Equine Vet J 2022 Mar;54(2):299-305.
    doi: 10.1111/evj.13443pubmed: 33630353google scholar: lookup
  25. Boyle AG, Stefanovski D, Rankin SC. Comparison of nasopharyngeal and guttural pouch specimens to determine the optimal sampling site to detect Streptococcus equi subsp equi carriers by DNA amplification.. BMC Vet Res 2017 Mar 23;13(1):75.
    doi: 10.1186/s12917-017-0989-4pmc: PMC5364677pubmed: 28335829google scholar: lookup

Citations

This article has been cited 0 times.